Bioinformatics Market Size Worth US$ 23.8 Billion by 2028 | CAGR: 14.3%: IMARC Group
IMARC Group, a leading market research company, has recently released a report titled “Bioinformatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global bioinformatics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Bioinformatics Market?
The global bioinformatics market size reached US$ 10.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 23.8 Billion by 2028, exhibiting a growth rate (CAGR) of 14.3% during 2023-2028.
What is Bioinformatics?
Bioinformatics is a multidisciplinary field that amalgamates biology, computer science, and information technology to decipher complex biological data and enhance the understanding of living organisms at a molecular level. It serves as an indispensable tool in the realm of life sciences, facilitating the analysis, interpretation, and management of vast biological datasets. In essence, bioinformatics acts as a bridge between biology and computational science, enabling researchers and scientists to extract valuable insights from the copious amounts of genetic, proteomic, and metabolic information available today.
Request for a PDF sample report: https://www.imarcgroup.com/bioinformatics-market/requestsample
What are the Growth Prospects and Trends in the Bioinformatics Industry?
Rapid genomic advancements represent one of the key factors driving the market growth across the globe. In line with this, the decoding of the human genome and subsequent breakthroughs in genome sequencing technologies have propelled bioinformatics into the forefront. The ability to sequence DNA rapidly and cost-effectively has led to an explosion of biological data, necessitating advanced computational tools for analysis and interpretation. This is driving the market toward growth significantly. Moreover, bioinformatics plays a pivotal role in drug discovery by facilitating the identification of potential drug targets, predicting drug interactions, and optimizing drug candidates. This accelerates the drug development process and reduces costs, thereby making it an invaluable asset for pharmaceutical companies, which is contributing to the market growth. In addition to this, the concept of tailoring medical treatments to an individual's genetic makeup is gaining traction.
Bioinformatics enables the analysis of a patient's genetic data to determine the most effective treatment strategies, thereby minimizing adverse effects and optimizing therapeutic outcomes. This is acting as a major growth-inducing factor. Other factors, such as significant agricultural advancements, the extensive utilization of machine learning (ML) and data analytics, favorable government initiatives promoting scientific innovation and address healthcare challenges, and extensive research and development (R&D) activities, are creating a positive outlook for the market further across the globe.
Who are the Key Players Operating in the Bioinformatics Market?
The report has also analysed the competitive landscape of the market with some of the key players.
- ABM Industries
- Agilent Technologies
- Biomax Informatics
- Data4Cure Inc.
- Dnaster Inc.
- Illumina Inc.
- Life Technologies
- PerkinElmer Inc.
- Qiagen N.V.
- Quest Diagnostics
- Sophia Genetics SA
- Thermo Fisher Scientific Inc.
- Waters Corp
- WuXi Nextcode Genomics
What is Included in Market Segmentation?
The report has categorized the market based on product and service, application and end-use sector.
Breakup by Product and Service:
- Knowledge Management Tools
- Generalized Knowledge Management Tools
- Specialized Knowledge Management Tools
- Bioinformatics Platforms
- Surgical Simulation Platforms
- Sequence Analysis, Alignment and Manipulation Platforms
- Structural and Functional Analysis Platforms
- Others
- Bioinformatics Services
- Data Analysis Services
- Database Management Services
- Others
Breakup by Application:
- Genomics
- Chemoinformatics and Drug Design
- Proteomics
- Transcriptomics
- Metabolomics
- Others
Breakup by End-Use Sector:
- Medical Biotechnology
- Academics
- Animal Biotechnology
- Agricultural Biotechnology
- Environmental Biotechnology
- Forensic Biotechnology
- Others
Regional Insights:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2129&flag=C
Key Highlights of The Report:
- Market Performance (2022-2027)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com
